tirzepatide new england journal of medicine In the SURMOUNT-1 trial (published in NEJM in July 2022), adults with #obesity treated with weekly tirzepatide, a glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor New research finds three years

If youve been scrolling through TikTok or Reddit lately, youve probably seen people talking about microdosing semaglutide as a way to lose weight, tame inflammation, and feel better without dealing with the harsh side effects that come with a full clinical dose

The molecular weight and structure of semaglutide do not exclude it from passive transfer into milk, unlike some larger antibody-based drugs that remain excluded

This tiny but powerful angiogenic chemical compound has the potential to be effective in treating neurodegenerative disorders caused by disease or traumatic injury

GLP-1 and the Gastrointestinal Tract 3

Maintain detailed records of daily doses and injection sites for consistent protocol adherence

The apparent effects on visceral fat may be explained by the metabolically active nature of this tissue and its response to overall weight reduction